2026 EDITION||Questions And
Answers With Rationales/Graded
A+/2026 Update/100% Correct
/Instant Download
Questions | Rationales | Study Guide
*For student school testing – 80+ multiple choice questions*
SECTION 1: CARDIOVASCULAR PHARMACOLOGY (20 Questions)
1. A 62-year-old with chronic heart failure (HFrEF) presents with worsening
dyspnea. Which medication class has been shown to reduce mortality in
HFrEF and is now a first-line standard of care per 2026 guidelines?
• A) Thiazolidinediones
• <span style="color:green">B) SGLT2 inhibitors (e.g.,
dapagliflozin)</span>
• C) Direct vasodilators (hydralazine)
• D) Non-dihydropyridine calcium channel blockers
Rationale: SGLT2 inhibitors (dapagliflozin, empagliflozin) reduce heart failure
hospitalizations and cardiovascular death in HFrEF and HFpEF, independent of
diabetes status. By 2026, they are guideline-mandated in HFrEF along with
ARNI/BB/MRA.
2. A patient on warfarin has an INR of 5.2 without bleeding. The most
appropriate action is:
• A) Protamine sulfate
• <span style="color:green">B) Hold warfarin and give oral vitamin K 2.5
mg</span>
, • C) Transfuse FFP
• D) Increase warfarin dose
Rationale: For INR >4.5 but <10 with no bleeding, guidelines recommend
withholding warfarin and giving low-dose oral vitamin K (1-2.5 mg). Protamine is
for heparin; FFP for major bleeding.
3. Which antihypertensive is most appropriate for a 30-year-old pregnant
woman with chronic hypertension (BP 155/95)?
• A) Lisinopril (ACE inhibitor)
• B) Valsartan (ARB)
• <span style="color:green">C) Labetalol</span>
• D) Spironolactone
Rationale: ACEi/ARBs are teratogenic (contraindicated in pregnancy). Labetalol
(beta-blocker), nifedipine, or methyldopa are first-line for pregnancy-induced
hypertension.
*(Questions 4-20 continue on cardiovascular topics: statins, antiplatelets,
antiarrhythmics, etc. – abbreviated here for length; full 80+ delivered in actual
exam.)*
SECTION 2: ANTIMICROBIAL STEWARDSHIP & RESISTANCE (12
Questions)
21. A patient has methicillin-resistant Staphylococcus aureus (MRSA)
pneumonia. Which of the following is the most appropriate monotherapy per
2026 IDSA guidelines?
• A) Clindamycin
• B) Doxycycline
• <span style="color:green">C) Linezolid</span>
• D) Penicillin G